Glucose News and Research

RSS

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Researchers determined the immune mechanisms associated with severe neurological manifestations of COVID-19.

7 Mar 2022

New inhibitor shows promise in fighting obesity and preventing heart disease

An interdisciplinary research team at The University of Texas at San Antonio has successfully developed an innovative inhibitor that shows promise in fighting obesity and potentially preventing heart disease.

4 Mar 2022

Researchers take pioneering efforts to optimize the functionality of pancreatic cells produced from stem cells

Helsingin yliopisto (University of Helsinki) Insulin is a vital hormone produced by pancreatic beta cells. Type 1 diabetes is caused by the destruction of these cells, which results in patients having to replace the lost insulin with multiple daily injections.

4 Mar 2022

Consuming wine with meals linked to lower risk of developing type 2 diabetes

An analysis of health data for nearly 312,400 current drinkers suggests consuming alcohol, most notably wine, with meals is associated with a lower risk of developing type 2 diabetes, according to preliminary research to be presented at the American Heart Association's Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2022.

4 Mar 2022

Visualizing health risks with medical imaging may discourage risk-related behaviors, finds study

They say a picture can convey a thousand words, and researchers have found that using medical imaging technologies that can visualize health may discourage risk-related behaviors more than non-visual information.

4 Mar 2022

Study identifies new ways to enhance SC-beta cell survivability through genetic manipulation

Recent advances in the transplantation of stem cell-derived insulin-producing beta cells (SC-beta cells) to treat type 1 diabetes (T1D) has generated considerable interest and excitement.

3 Mar 2022

Improvements needed in diagnosis and treatment of people with prediabetes, study says

According to the U.S. Centers for Disease Control and Prevention, prediabetes is a serious health condition in which blood sugar levels are higher than normal, but not high enough to meet the threshold for type 2 diabetes.

3 Mar 2022

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications.

3 Mar 2022

Study illustrates the link between e-cigarette use and increased odds of prediabetes

An analysis of data from a large, nationally representative survey of the US population shows that e-cigarette use is associated with increased odds of prediabetes.

3 Mar 2022

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Researchers at Massachusetts General Hospital, in partnership with NYU Langone Health, have launched a multi-center clinical trial to investigate a new treatment for pediatric type 1 diabetes even in subjects with established disease.

1 Mar 2022

Research shows intergenerational effects of preconception opioids in male offspring rats

New research from scientists at Cummings School of Veterinary Medicine at Tufts University suggests opioid use before pregnancy - even if not used during pregnancy itself - could result in a higher likelihood that a mother's male offspring will develop type 2 diabetes and metabolic syndrome, conditions that increase the risk of heart disease and stroke.

28 Feb 2022

New dialysis system shows ability to make sterile, medical grade water at the point-of-care

Findings from preliminary tests of a new dialysis system have confirmed its ability to make sterile, medical grade water to provide an affordable, accessible home-based treatment option for patients with kidney failure.

27 Feb 2022

Researchers untangle the mysteries around type-2 diabetes

For more than 30 years, scientists have been trying to unravel the mystery of how a key biological molecule self assembles into a rogue protein-like substance known as amyloid, which is thought to play a role in the development of type-2 diabetes - a disease that affects 300 million people worldwide.

25 Feb 2022

Melatonin as a safe and potentially life-saving treatment for COVID-19

A new study discusses the possible role of melatonin, an antioxidant and anti-inflammatory agent, in treating COVID-19.

24 Feb 2022

White blood cell count as a prognostic indicator of COVID-19

Based on a new study, researchers concluded WBC count variations worsen clinical outcomes such as severity, mortality, and hospital discharge rates leading to a poorer prognosis in COVID-19 patients.

23 Feb 2022

Study explores the impact of COVID-19 on pancreatic cells

New study findings showed that SARS-CoV-2 caused a productive yet restricted infection of pancreatic islet cells and an insignificant inflammatory response.

23 Feb 2022

High-fiber diet linked with reduced risk of developing dementia

We're always hearing that we should eat more fiber. It's known to be vitally important for a healthy digestive system and also has cardiovascular benefits like reduced cholesterol.

21 Feb 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Melanoma, a type of skin cancer, is often curable when detected and treated in its early stages. However, the disease can rapidly spread to other organs in the body and become deadly. According to the American Cancer Society, more than 7,600 people die of the disease each year in the United States.

17 Feb 2022

Regular physical activity at 70 may help ward off heart disease in old age

Twenty minutes of daily moderate to vigorous exercise in early old age (70-75) may best stave off major heart disease, including heart failure, in late old age (80+), suggests research published online in the journal Heart.

15 Feb 2022

Glucose News and Research

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

New inhibitor shows promise in fighting obesity and preventing heart disease

Researchers take pioneering efforts to optimize the functionality of pancreatic cells produced from stem cells

Consuming wine with meals linked to lower risk of developing type 2 diabetes

Visualizing health risks with medical imaging may discourage risk-related behaviors, finds study

Study identifies new ways to enhance SC-beta cell survivability through genetic manipulation

Improvements needed in diagnosis and treatment of people with prediabetes, study says

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Study illustrates the link between e-cigarette use and increased odds of prediabetes

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Research shows intergenerational effects of preconception opioids in male offspring rats

New dialysis system shows ability to make sterile, medical grade water at the point-of-care

Researchers untangle the mysteries around type-2 diabetes

Melatonin as a safe and potentially life-saving treatment for COVID-19

White blood cell count as a prognostic indicator of COVID-19

Study explores the impact of COVID-19 on pancreatic cells

High-fiber diet linked with reduced risk of developing dementia

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Regular physical activity at 70 may help ward off heart disease in old age

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News